What are the areas in which the listed chemical companies that make money in 2025 are distributed?

Market Overview

in 2025, China's chemical industry is in the adjustment period of cycle bottoming and structural optimization. This study is based on the data of more than 700 listed companies on the flush platform, covering 27 sub-sectors, and systematically analyzes the earnings performance of each sub-sector.

High profitability segment (average margin 22% +)

pharmaceutical industry chain outstanding performance. Chemical preparations (average profit margin of more than 22%) is the downstream link of medicine, the expected profit margin of enterprises such as the Palace can exceed 25%, the driving force from the pharmaceutical needs, the aging of the population and technical barriers. API (average profit margin of about 22%) is located upstream, Haisheng Pharmaceuticals and Senxuan Pharmaceuticals annual profit margin is expected to exceed 30%. Environmental protection and quality supervision eliminate inefficient production capacity and promote industry concentration and profit margins.

rubber deep processing benefit from the new energy industry chain. Other rubber products (excluding tires, with an average profit margin of about 22%) include seals, O-rings, hoses, etc. Litong Technology and Cologne New Materials earn more than 24%. New energy vehicles for battery packs, motor high-performance sealing materials demand surge.

Oil and gas exploitation and service(average profit margin of about 22%) benefited from the policy dividend. In 2025, the state will gradually liberalize exploration and exploitation rights, and CNOOC, new natural gas and other enterprises will make outstanding profits. Silicone maintain a profit margin of about 22%, benefiting from demand for photovoltaics and new energy vehicles.

Low profitability segment (average profit margin <3%)

gas field(28 listed enterprises) are facing the dual pressure of policy control and market: the price of gas source fluctuates but the end price is subject to regulatory restrictions, the cost of infrastructure is high, and the pressure of new energy substitution increases.

Traditional chemical products encountered overcapacity and weak demand squeeze. The polyurethane dilemma stems from the release of raw material capacity such as MDI and TDI leading to lower prices and weak downstream demand for construction and home appliances. The overall profit margin of Sinopec, PetroChina and other giants in the oil processing trade is not high, and several enterprises are facing losses.

The dilemma of chemical fibers stems from the sluggish demand for textiles and clothing, and the overcapacity of polyester and nylon has triggered a price war. Plastic products (about 75 listed companies) are facing the impact of raw material price fluctuations, weak demand, and the "plastic limit order" policy. However, companies such as Lanxiao Technology have achieved higher profitability through differentiated competition. Other chemicals (coatings, pigments, adhesives, etc.) have small batches and high research and development costs.

Investment Inspiration

priority layout: The pharmaceutical industry chain (chemical agents, raw materials) has long-term growth support, new energy-related rubber seals, silicone in a high-speed growth period, oil and gas exploration policy opening up to create new opportunities.

Careful assessment: Traditional bulk chemicals (petroleum processing, polyurethane, chemical fiber, plastics) are facing overcapacity and weak demand, and the price war is fierce.

Strategic core: Migration to high value-added links, new energy reshaping demand structure, differentiated competition and technology upgrading is the way to break through.

Data description: 2025 profit data is based on the enterprise performance forecast, flush forecast and the first three quarters of data calculation, for reference only.